Indra Reddy named Founding Dean Emeritus of Irma Lerma Rangel School of Pharmacy

The Texas A&M University System Board of Regents has honored Indra K. Reddy, PhD, with the prestigious title of Founding Dean Emeritus of the Texas A&M University Irma Lerma Rangel School of Pharmacy. This honor recognizes his distinguished and dedicated service during his illustrious 20-year tenure as the founding dean, during which he transformed the school into one of the nation’s leading institutions.

“I am deeply honored to be recognized as the Founding Dean Emeritus of the Rangel School of Pharmacy,” Reddy said. “This honor is a testament to the collaborative efforts and unwavering dedication of our exceptional faculty, committed staff and hard-working students. Together, we have built a foundation of excellence in pharmacy education, research, patient care and community service.”

Reddy joined the Rangel School of Pharmacy in 2004 and spearheaded the establishment of the first professional health program south of San Antonio. The school opened its doors in Kingsville in 2006 to address the critical need for pharmacists in the region. The first cohort graduated in 2010, and by 2012, the school was ranked among the top 50 pharmacy schools in the nation by U.S. News & World Report.

Under Reddy’s visionary leadership, the college experienced exceptional growth, expanding to the College Station campus in 2014. He skillfully managed teams on both campuses, bridging the 300-mile gap to unify cohorts and synchronize all college affairs. In 2023, he initiated the new Aggie Pharmacy Technician Program to address the pharmacy technician shortage in Texas.

“Reddy’s remarkable 20-year journey as the dean of pharmacy at Texas A&M has left an indelible mark on the institution, its students and the field of pharmacy itself. His legacy of excellence, mentorship and innovation will continue to inspire us and lead future generations to a brighter and more compassionate future in the world of pharmacy,” said Mansoor Khan, PhD, interim dean of the School of Pharmacy and University Distinguished Professor.

Among his numerous accomplishments, Reddy has been instrumental in expanding the college’s research enterprise. In 2021, he launched a new PhD program in pharmaceutical sciences and recruited top researchers, including several RO1-funded faculty members. In 2022, the college set a record by surpassing $10 million in research funding, ranking 31st out of 113 pharmacy schools in the national standings for total research funding for the 2021-22 academic year, according to the American Association of Colleges of Pharmacy (AACP). That same year, the School of Pharmacy had the highest funding density among Texas pharmacy schools, with $149,132.48 in funding per faculty member.

“The ‘Pharmily,’ as Dr. Reddy affectionately named it, expresses its deepest gratitude for his outstanding contributions to the School of Pharmacy during his years as dean. His legacy will continue to inspire and shape the future of pharmacy education and research at the university and beyond,” Khan said.

Reflecting on his tenure, Reddy said, “I am proud of what we have achieved together and look forward to the continued growth and success of the School of Pharmacy as it advances the frontiers of pharmaceutical science, pharmacy practice and health care.”

While still on the faculty as a professor of pharmaceutical sciences, Reddy left his deanship in 2023 to lead the Texas A&M University Health Science Center (Texas A&M Health) as interim chief operating officer and senior vice president.